Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
| ▸ | HTR2C | P28335 | 1/20 | 0.43 |
| ▸ | HTR2B | P41595 | 1/20 | 0.43 |
| ▸ | MGAM | O43451 | 6/20 | 0.41 |
| ▸ | GAA | P10253 | 6/20 | 0.41 |
| ▸ | SI | P14410 | 6/20 | 0.41 |
| ▸ | MGAM2 | Q2M2H8 | 6/20 | 0.41 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.40 |
| ▸ | PGR | P06401 | 1/20 | 0.40 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.40 |
| ▸ | AR | P10275 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | MC4R | P32245 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18364658 | 0.86 | MAPT (0.46) | MEN1MAPTKMT2ATDP1NPSR1 | |
| SCHEMBL18364666 | 0.82 | HTR2A (0.48) | MEN1MAPTKMT2ATDP1NPSR1 | |
| SCHEMBL18364645 | 0.74 | GPR84 (0.62) | MEN1MAPTKMT2ATDP1GPR84 | |
| SCHEMBL18364652 | 0.74 | GPR84 (0.54) | MEN1MAPTKMT2ATDP1NPSR1 | |
| Vibrindole A SCHEMBL5960513 | 0.73 | GPR84 (0.71) | MEN1MAPTKMT2ATDP1GPR84 | |
| SCHEMBL27941133 | 0.73 | GPR84 (0.57) | MEN1MAPTKMT2AGPR84FFAR1 | |
| SCHEMBL487544 | 0.72 | PLAU (0.53) | MAPTTDP1GAACYP1A2ALDH1A1 | |
| SCHEMBL18364660 | 0.72 | GPR84 (0.56) | MEN1MAPTKMT2ATDP1NPSR1 | |
| SCHEMBL18364648 | 0.70 | GPR84 (0.50) | MEN1MAPTKMT2ATDP1GPR84 | |
| SCHEMBL19350942 | 0.70 | GPR84 (0.53) | MEN1MAPTKMT2ATDP1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170008843-A1 | MONOMER, ORGANIC LAYER COMPOSITION, ORGANIC LAYER, AND METHOD OF FORMING PATTERNS | SAMSUNG SDI CO., LTD. (KR) | 2017-01-12 | — | — | US | disclosed |
| US-20170008843-A1 | MONOMER, ORGANIC LAYER COMPOSITION, ORGANIC LAYER, AND METHOD OF FORMING PATTERNS | SAMSUNG SDI CO., LTD. (KR) | 2017-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170008843-A1 | MONOMER, ORGANIC LAYER COMPOSITION, ORGANIC LAYER, AND METHOD OF FORMING PATTERNS | MSMO1, NOM1, CD68 | MEN1 407/4885MAPT 293/4885KMT2A 3422/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.